Cite
HARVARD Citation
Nomura, S. et al. (2020). A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study). Japanese journal of clinical oncology. pp. 821-825. [Online].